NCT02466347View on ClinicalTrials.gov

Bioequivalence Study of Synflutide HFA Inhaler and Seretide Evohaler in Healthy Volunteers Without Charcoal Block

PHASE1CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions
AsthmaChronic Obstructive Pulmonary Disease (COPD)
Interventions
DRUG

Fluticasone propionate

Inhaled corticosteroid, pMDI

DRUG

Salmeterol (as xinafoate)

Long Acting Beta-agonist (LABA), pMDI

Trial Locations (1)

Unknown

Clinical Pharmacology Unit of Mackay Memorial Hospital Tamshui Branch, New Taipei City

Sponsors
All Listed Sponsors
lead

Intech Biopharm Ltd.

INDUSTRY

NCT02466347 - Bioequivalence Study of Synflutide HFA Inhaler and Seretide Evohaler in Healthy Volunteers Without Charcoal Block | Biotech Hunter | Biotech Hunter